Alembic Pharma
BSE: 533573
|
NSE: APLLTD
Alembic Pharma
(CIN: L24230GJ2010PLC061123)
operates in the Pharmaceuticals industry and has been listed in the stock market since 20 Sep 2011.
It currents trades on NSE with symbol APLLTD and on BSE with scrip code 533573.
The registered office of the company is Alembic Road, , Vadodara, Gujarat - 390003.
The management team of Alembic Pharma is led by Chirayu Amin who is the Chairperson. Other members of the management team consist of Chirayu Ramanbhai Amin (Designation:Executive Director-Chairperson related to Promoter-CEO), Pranav Chirayu Amin (Designation:Executive Director-MD), Shaunak Chirayu Amin (Designation:Executive Director-MD), Ashok Kumar Barat (Designation:Non-Executive - Independent Director), Jai Shishir Diwanji (Designation:Non-Executive - Independent Director), Manish Santoshkumar Kejriwal (Designation:Non-Executive - Independent Director), Geeta Amit Goradia (Designation:Non-Executive - Independent Director), Raj Kumar Baheti (Designation:Executive Director), Ajay Kumar Desai (Designation:Sr. Vice President-Finance), G Krishnan (Designation:Chief Financial Officer), Manisha Saraf (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Alembic Pharma is as below -
The registered office of the company is Alembic Road, , Vadodara, Gujarat - 390003.
The management team of Alembic Pharma is led by Chirayu Amin who is the Chairperson. Other members of the management team consist of Chirayu Ramanbhai Amin (Designation:Executive Director-Chairperson related to Promoter-CEO), Pranav Chirayu Amin (Designation:Executive Director-MD), Shaunak Chirayu Amin (Designation:Executive Director-MD), Ashok Kumar Barat (Designation:Non-Executive - Independent Director), Jai Shishir Diwanji (Designation:Non-Executive - Independent Director), Manish Santoshkumar Kejriwal (Designation:Non-Executive - Independent Director), Geeta Amit Goradia (Designation:Non-Executive - Independent Director), Raj Kumar Baheti (Designation:Executive Director), Ajay Kumar Desai (Designation:Sr. Vice President-Finance), G Krishnan (Designation:Chief Financial Officer), Manisha Saraf (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Alembic Pharma is as below -
Volume: 4,702.00
M. Cap: 15,163.83
P/E: 22.60
Prev. Close: 783.00
Day
52 Wk
Volume: 21,774.00
M. Cap: 15,163.83
P/E: 22.60
Prev. Close: 780.65
Day
52 Wk
Stock Price Chart
F&O Data
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 13,70,81,813 | 69.74 |
| Pledge | 0 | 0.00 |
| Foreign Institutions | 83,61,504 | 4.26 |
| Financial Institutions | 3,17,47,127 | 16.14 |
| NBFC and Mutual Funds | 1,60,83,228 | 8.18 |
| Others | 1,93,72,680 | 9.86 |
| Total | 21,26,46,352 | 108.18 |
Financial Data
Consolidated
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 6,672.08 | 6,228.63 | 5,652.62 |
| Operating Profit | 1,064.53 | 960.69 | 680.19 |
| Other Income | 56.29 | 28.30 | 2.74 |
| Interest | 78.77 | 56.19 | 50.17 |
| Depreciation | 278.58 | 272.67 | 275.43 |
| Profit Before Tax | 707.18 | 631.83 | 354.59 |
| Tax | 125.17 | 16.01 | 12.60 |
| Profit After Tax | 582.01 | 615.82 | 341.99 |
| Share Capital | 39.31 | 39.31 | 39.31 |
| Reserves | 5,151.63 | 4,778.89 | 4,331.16 |
| Net Worth | 5,190.94 | 4,818.20 | 4,370.47 |
| Loans | 1,381.81 | 622.67 | 828.22 |
| Gross Block | 4,117.32 | 3,875.19 | 3,467.50 |
| Investments | 127.21 | 93.02 | 96.33 |
| Cash | 90.10 | 126.57 | 82.27 |
| Debtors | 1,399.79 | 1,024.84 | 1,046.40 |
| Net Working Capital | 3,083.36 | 2,276.78 | 2,102.63 |
| Operating Profit Margin (%) | 15.95 | 15.42 | 12.03 |
| Net Profit Margin (%) | 8.72 | 9.89 | 6.05 |
| EPS | 29.68 | 31.33 | 17.40 |
| Dividend (%) | 550.00 | 550.00 | 400.00 |
| Dividend Payout | 216.22 | 157.25 | 196.56 |
Standalone
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 6,032.63 | 5,874.06 | 5,149.00 |
| Operating Profit | 962.14 | 1,029.84 | 667.88 |
| Other Income | 60.75 | 504.88 | 3.55 |
| Interest | 76.47 | 54.47 | 49.00 |
| Depreciation | 277.08 | 271.14 | 272.95 |
| Profit Before Tax | 608.59 | 704.23 | 345.93 |
| Tax | 105.47 | 37.75 | -0.80 |
| Profit After Tax | 503.12 | 666.48 | 346.73 |
| Share Capital | 39.31 | 39.31 | 39.31 |
| Reserves | 5,155.43 | 4,869.60 | 4,374.98 |
| Net Worth | 5,194.74 | 4,908.91 | 4,414.29 |
| Loans | 1,318.24 | 601.50 | 816.13 |
| Gross Block | 4,100.64 | 3,859.15 | 3,605.68 |
| Investments | 259.56 | 226.68 | 229.27 |
| Cash | 20.85 | 26.49 | 28.46 |
| Debtors | 1,480.67 | 1,340.12 | 1,201.20 |
| Net Working Capital | 2,902.72 | 2,223.71 | 2,022.42 |
| Operating Profit Margin (%) | 15.95 | 17.53 | 12.97 |
| Net Profit Margin (%) | 8.34 | 11.35 | 6.73 |
| Earning Per Share (Rs) | 25.60 | 33.91 | 17.64 |
| Dividend (%) | 550.00 | 550.00 | 400.00 |
| Dividend Payout | 216.22 | 0.00 | 196.56 |
Dividend Declared (₹)
The company has declared dividend 5 times between 19 Jul 2021 and 29 Jul 2025, totaling Rs. 54.00 so far. The most recent dividend was declared on 29 Jul 2025 for Rs. 11.
Financial Data Graph
The peers of Alembic Pharma are LUPIN, IPCALAB and ABBOTINDIA. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.